Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants

Résumé

Background Antiretroviral drugs for preventing mother-to-child transmission (PMTCT) can lead to NRTI resistance in infants who contract HIV despite prophylaxis. We aimed to assess how different post-natal prophylaxis (PNP) strategies; nevirapine (NVP) alone vs zidovudine (ZDV) alone vs dual NVP + ZDV influenced NRTI resistance prevalence. Methods We analyzed data from nationally representative HIV drug resistance surveys conducted in Kenya where the standard practice was the use of dual NVP + ZDV and Nigeria where the standard practice was the use of NVP PNP. HIV drug resistance was determined using population-based sequencing, and mutations interpreted using the Stanford HIVdb algorithm. Analyses were weighted for multistage sampling and genotyping success rates. Results Among 557 HIV-infected infants aged <18 months with data on resistance and type of PNP, 29.3% received dual NVP + ZDV PNP, 24.6% received NVP alone, 2.3% received ZDV alone, and 43.8% received no PNP. The prevalence of NRTI resistance was 19.4% (95%CI 15.2–24.3) in Nigeria and 9.6% (95%CI 6.6–13.8) in Kenya ( p < 0.001). Resistance to abacavir, lamivudine, zidovudine and tenofovir were 2- to 4.5-fold higher in Nigerian HIV infected infants exposed to NVP PNP compared to Kenyan infants exposed to NVP + ZDV. The proportion of infants with NNRTI resistance was 49% (95%CI 43.5–54.5) and 43.8% (95%CI 38.0–49.7), in Nigeria and Kenya respectively ( p = 0.204). Conclusions These findings suggest an association between type of PNP and the development of NRTI resistance in HIV-infected infants. Dual-drug prophylaxis was associated with a low prevalence of NRTI resistance compared to single-drug PNP. Our findings highlight the need for further research on combination prophylactic strategies in minimizing the emergence of drug resistance in this population.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0